Form 4 for CRMD CorMedix Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-12 · accession 0001213900-25-087374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-12 | 2025-09-12 | CRMD | Todisco Joseph | CEO | S - Sale+OE | $13.00 | -50.0K | 509.5K | -9% | -$650.0K |
| D | 2025-09-12 | 2025-09-12 | CRMD | Todisco Joseph | CEO | M - OptEx | $3.47 | +50.0K | 559.5K | +10% | +$173.5K |
| D | 2025-09-12 | 2025-09-12 | CRMD | Todisco Joseph | CEO | M - OptEx | $0.00 | -50.0K | 216.7K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-12 | S | D | 50,000 | $13.00 | 509,496 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2025-09-12 | M | A | 50,000 | $3.47 | 559,496 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-09-12 | M | D | 50,000 | $0.00 | 216,667 | D | $3.47 · — to 2034-01-11 | 50,000 Common Stock | (F2) These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |